In:
Blood, American Society of Hematology, Vol. 124, No. 11 ( 2014-09-11), p. 1715-1726
Abstract:
Endothelial-restricted complement activation occurs in aHUS, and clinical remission relies on efficient endothelial complement inhibition. Ex vivo serum-induced endothelial C5b-9 deposits are a sensitive tool to monitor complement activation and eculizumab effectiveness in aHUS.
Type of Medium:
Online Resource
ISSN:
0006-4971
,
1528-0020
DOI:
10.1182/blood-2014-02-558296
Language:
English
Publisher:
American Society of Hematology
Publication Date:
2014
detail.hit.zdb_id:
1468538-3
detail.hit.zdb_id:
80069-7
Permalink